An Open-Label, Safety and Efficacy Study of Cebranopadol in Participants With Acute Pain With Surgical or Non-Surgical Origin
Public ClinicalTrials.gov record NCT07845071. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Single-Arm, Multiple-Dose, Phase 3 Safety and Efficacy Study of Cebranopadol in Participants With Moderate to Severe Acute Pain With Surgical or Non-Surgical Origin
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety and effectiveness of cebranopadol in treating acute pain.
Study identification
- NCT ID
- NCT07845071
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 160 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 22, 2026 (Actual)
- Primary completion
- Jan 2027 (Estimated)
- Completion
- Feb 2027 (Estimated)
- Last update posted
- Sep 30, 2026
2026 – 2027
United States locations
- U.S. sites
- 15
- U.S. states
- 10
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Adneuris Site 001115 | Phoenix | Arizona | 85053 | Recruiting |
| Adneuris Site 001118 | Riverside | California | 92504 | Recruiting |
| Adneuris Site 001119 | Longmont | Colorado | 80501 | Recruiting |
| Adneuris Site 001122 | Savannah | Georgia | 31406 | Not yet recruiting |
| Adneuris Site 001123 | O'Fallon | Illinois | 62269 | Not yet recruiting |
| Adneuris Site 001125 | Annapolis | Maryland | 21401 | Recruiting |
| Adneuris Site 001120 | Oradell | New Jersey | 07649 | Recruiting |
| Adneuris Site 001124 | Tulsa | Oklahoma | 74137 | Recruiting |
| Adneuris Site 001110 | Bellaire | Texas | 77401 | Not yet recruiting |
| Adneuris Site 001117 | Forney | Texas | 75126 | Recruiting |
| Adneuris Site 001104 | McAllen | Texas | 78501 | Recruiting |
| Adneuris Site 001116 | Plano | Texas | 75093 | Not yet recruiting |
| Adneuris Site 001111 | San Antonio | Texas | 78240 | Not yet recruiting |
| Adneuris Site 001121 | San Antonio | Texas | 78240 | Not yet recruiting |
| Adneuris Site 001101 | Salt Lake City | Utah | 84107 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07845071, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 30, 2026 · Synced Oct 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07845071 live on ClinicalTrials.gov.